Platelet-activating factor-induced clathrin-mediated endocytosis requires β-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 7039-7050

  McLaughlin, Nathan J D ^a   Banerjee, Anirban ^b   Kelner, Marguerite R ^b   Gamboni Robertson, Fabia ^b   Hamiel, Christine ^b   Sheppard, Forest R ^b,c   Moore, Ernest E ^b,c   Silliman, Christopher C ^a,b,d  

^a University of Colorado School of Medicine   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d Bonfils Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; APOPTOSIS SIGNAL REGULATING KINASE 1; BETA ARRESTIN 1; CLATHRIN; DYNAMIN II; FASCIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOCYTE SPECIFIC PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PHOSPHOTRANSFERASE; RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CELL ORGANELLE; CELL STIMULATION; ENDOCYTOSIS; ENDOSOME; ENZYME INHIBITION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SIGNALOSOME; WHOLE CELL;

EID: 33646868636     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.7039     Document Type: Article

References (49)

1. von Zastrow, M. 2003. Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci. 74: 217-224.
2. Luttrell, L. M., and R. J. Lefkowitz. 2002. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115: 455-465.
3. Ferguson, S. S. 2001. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53: 1-24.
4. Pierce, K. L., L. M. Luttrell, and R. J. Lefkowitz. 2001. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20: 1532-1539.
5. McCudden, C. R., M. D. Hains, R. J. Kimple, D. P. Siderovski, and F. S. Willard. 2005. G-protein signaling: back to the future. Cell Mol. Life Sci. 62: 551-577.
6. McDonald, P. H., and R. J. Lefkowitz. 2001. β-Arrestins: new roles in regulating heptahelical receptors' functions. Cell. Signal. 13: 683-689.
7. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84: 1045-1049.
8. 4. Blood 64: 780-785.
9. Green, S. P., A. Chuntharapai, and J. T. Curnutte. 1996. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor. J. Biol. Chem. 271: 25400-25405.
10. Ingraham, L. M., T. D. Coates, J. M. Allen, C. P. Higgins, R. L. Baehner, and L. A. Boxer. 1982. Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood 59: 1259-1266.
11. Pedraza, L., G. C. Owens, L. A. Green, and J. L. Salzer. 1990. The myelin-associated glycoproteins: membrane disposition, evidence of a novel disulfide linkage between immunoglobulin-like domains, and posttranslational palmitylation. J. Cell Biol. 111: 2651-2661.
12. Silliman, C. C., N. F. Voelkel, J. D. Allard, D. J. Elzi, R. M. Tuder, J. L. Johnson, and D. R. Ambruso. 1998. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J. Clin. Invest. 101: 1458-1467.
13. Chen, Z., D. J. Dupre, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova. 2002. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motif. J. Biol. Chem. 277: 7356-7362.
14. Silliman, C. C., K. L. Clay, G. W. Thurman, C. A. Johnson, and D. R. Ambruso. 1994. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med. 124: 684-694.
15. Ambruso, D. R., B. G. Bolscher, P. M. Stokman, A. J. Verhoeven, and D. Roos. 1990. Assembly and activation of the NADPH:O2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J. Biol. Chem. 265: 924-930.
16. Silliman, C. C., D. J. Elzi, D. R. Ambruso, R. J. Musters, C. Hamiel, R. J. Harbeck, A. J. Paterson, A. J. Bjornsen, T. H. Wyman, M. Kelher, et al. 2003. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukocyte Biol. 73: 511-524.
17. Monks, C. R., B. A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82-86.
18. Weiner, O. D., G. Servant, M. D. Welch, T. J. Mitchison, J. W. Sedat, and H. R. Bourne. 1999. Spatial control of actin polymerization during neutrophil chemotaxis. Nat. Cell Biol. 1: 75-81.
19. Wouters, F. S., P. I. Bastiaens, K. W. Wirtz, and T. M. Jovin. 1998. FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid oxidation enzymes in peroxisomes. EMBO J. 17: 7179-7189.
20. Perron, A., Z.-G. Chen, D. Gingras, D. J. Dupré, J. Staòková, and M. Rola-Pleszczynski. 2003. Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization. J. Biol. Chem. 278: 27956-27965.
21. Rane, M. J., Y. Pan, S. Singh, D. W. Powell, R. Wu, T. Cummins, Q. Chen, K. R. McLeish, and J. B. Klein. 2003. Heat shock protein 27 controls apoptosis by regulating Akt activation. J. Biol. Chem. 278: 27828-27835.
22. Nick, J. A., N. J. Avdi, S. K. Young, C. Knall, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1997. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99: 975-986.
23. Schaefer, A. W., H. Kamiguchi, E. V. Wong, C. M. Beach, G. Landreth, and V. Lemmon. 1999. Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J. Biol. Chem. 274: 37965-37973.
24. Benard, O., Z. Naor, and R. Seger. 2001. Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone. J. Biol. Chem. 276: 4554-4563.
25. Lee, S. H., M. Eom, S. J. Lee, S. Kim, H. J. Park, and D. Park. 2001. β-Pix-enhanced p38 activation by Cdc42/Rac/PAK/MKK3/6-mediated pathway: implication in the regulation of membrane ruffling. J. Biol. Chem. 276: 25066-25072.
26. Terada, Y., O. Nakashima, S. Inoshita, M. Kuwahara, S. Sasaki, and F. Marumo. 1999. TGF-β-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int. 56: 1378-1390.
27. Huot, J., F. Houle, S. Rousseau, R. G. Deschesnes, G. M. Shah, and J. Landry. 1998. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J. Cell Biol. 143: 1361-1373.
28. Huang, C. K., L. Zhan, Y. Ai, and J. Jongstra. 1997. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272: 17-19.
29. Dupré, D. J., Z. Chen, G. C. Le, C. Thériault, J.-L. Parent, M. Rola-Pleszczynski, and J. Stankova. 2003. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor. J. Biol. Chem. 278: 48228-48235.
30. Ahn, S., C. D. Nelson, T. R. Garrison, W. E. Miller, and R. J. Lefkowitz. 2003. Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference. Proc. Natl. Acad. Sci. USA 100: 1740-1744.
31. Daaka, Y., L. M. Luttrell, S. Ahn, G. J. Della Rocca, S.S. Ferguson, M. G. Caron, and R. J. Lefkowitz. 1998. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J. Biol. Chem. 273: 685-688.
32. Chen, Z., M. Rola-Pleszczynski, and J. Stankova. 2003. Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalisation and G-protein activation. Cell. Signal. 15: 843-850.
33. Kim, Y. M., and J. L. Benovic. 2002. Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking. J. Biol. Chem. 277: 30760-30768.
34. Laporte, S. A., W. E. Miller, K. M. Kim, and M. G. Caron. 2002. β-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a β-arrestin hinging site in β2-adaptin. J. Biol. Chem. 277: 9247-9254.
35. Luttrell, L. M., S. S. Ferguson, Y. Daaka, W. E. Miller, S. Maudsley, G. J. Della Rocca, F. Lin, H. Kawakatsu, K. Owada, D. K. Luttrell, et al. 1999. β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283: 655-661.
36. Barlic, J., J. D. Andrews, A. A. Kelvin, S. E. Bosinger, M. E. DeVries, L. Xu, T. Dobransky, R. D. Feldmah, S. S. Ferguson, and D. J. Kelvin. 2000. Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCRI. Nat. Immunol. 1: 227-2331
37. McDonald, P. H., C. W. Chow, W. E. Miller, S. A. Laporte, M. E. Field, F. T. Lin, R. J. Davis, and R. J. Lefkowitz. 2000. β-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290: 1574-1577.
38. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
39. Tobiume, K., A. Matsuzawa, T. Takahashi, H. Nishitoh, K. Morita, K. Takeda, O. Minowa, K. Miyazono, T. Noda, and H. Ichijo. 2001. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2: 222-228.
40. Ichijo, H., E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94.
41. Monta, K., M. Saitoh, K. Tobiume, H. Matsuura, S. Enomoto, H. Nishitoh, and H. Ichijo. 2001. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20: 6028-6036.
42. Hoeflich, K. P., W. C. Yeh, Z. Yao, T. W. Mak, and J. R. Woodgett. 1999. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 18: 5814-5820.
43. Gotoh, Y., and J. A. Cooper. 1998. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction. J. Biol. Chem. 273: 17477-17482.
44. Saitoh, M., H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17: 2596-2606.
45. Murray, J., J. A. Barbara, S. A. Dunkley, A. F. Lopez, X. Van Ostade, A. M. Condliffe, I. Dransfield, C. Haslett, and E. R. Chilvers. 1997. Regulation of neutrophil apoptosis by tumor necrosis factor-α: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772-2783.
46. Sun, Y., Z. Cheng, L. Ma, and G. Pei. 2002. β-Arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277: 49212-49219.
47. Duh, F. M., F. Latif, Y. Weng, L. Geil, W. Modi, T. Stackhouse, F. Matsumura, D. R. Duan, W. M. Linehan, M. I. Lerman, et al. 1994. cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol. 13: 821-827.
48. Zhang, Q., Y. Li, and T. H. Howard. 2000. Human lymphocyte-specific protein 1, the protein overexpressed in neutrophil actin dysfunction with 47-kDa and 89-kDa protein abnormalities (NAD 47/89), has multiple F-actin binding domains. J. Immunol. 165: 2052-2058.
49. Glenney, J. R., Jr., N. Geisler, P. Kaulfus, and K. Weber. 1981. Demonstration of at least two different actin-binding sites in villin, a calcium-regulated modulator of F-actin organization. J. Biol. Chem. 256: 8156-8161.